FDA Flags Hamilton Medical Ventilators and Breathing Circuits Over Serious Safety Risks

Class I recall and correction highlight vulnerabilities in anesthesia and respiratory care equipment

The U.S. Food and Drug Administration (FDA) has issued multiple Class I safety actions against products manufactured by Hamilton Medical, a leading supplier of ventilators and respiratory support systems. The recalls cover both coaxial breathing circuit sets and the Hamilton-C6 ventilator, with identified defects posing serious risks of ventilation failure in critical care and perioperative settings.

The agency’s actions reflect growing regulatory attention on the reliability of respiratory devices—tools that are central to surgery, anesthesia, and intensive care.

1. Breathing Circuit Sets Recall

Hamilton Medical recalled certain lots of its coaxial breathing circuit sets after reports of cracks in the inner blue tube. These cracks compromise the integrity of the breathing circuit, leading to potential leaks, reduced ventilation efficiency, or complete airflow interruption.

Because these circuits are used for anesthesia delivery and mechanical ventilation, a defect of this nature could result in hypoventilation, desaturation, or respiratory arrest if not detected immediately.

2. Hamilton-C6 Ventilator Class I Correction

The FDA also announced a Class I correction for the Hamilton-C6 ventilator. Investigations revealed a defective circuit board within the ventilator that may cause interruption of ventilation during use.

Ventilator interruption poses severe risks, particularly for patients who are fully dependent on the device for respiratory support. The FDA warned that failures may result in hypoxia, brain injury, or death if backup ventilation is not promptly initiated.

Both actions were classified as Class I, the FDA’s highest risk category, reserved for defects with a reasonable probability of causing serious harm or death.

Critical Role in Anesthesia and ICU Care: Breathing circuits and ventilators are indispensable in surgery and intensive care. Failures could jeopardize patient stability in high-acuity settings.

Hidden Risks: Cracks in circuit tubing or internal ventilator faults may not be immediately visible, leaving clinicians vulnerable to sudden device failures during procedures.

Supply Chain Impact: Hamilton Medical products are widely used across U.S. hospitals. Recalls of this scale can disrupt OR readiness, ICU workflows, and hospital procurement strategies.

Financial Strain: Hospitals must allocate funds for replacements, biomedical audits, and staff retraining—adding to the burden of already strained operating budgets.

Anesthesiologists and Nurse Anesthetists: Require assurance that breathing circuits used in ORs are free from cracks or leaks.

Respiratory Therapists and Intensivists: Must closely monitor Hamilton-C6 ventilator performance and implement manufacturer updates.

Biomedical Engineering Teams: Tasked with auditing inventories, testing for defects, and coordinating with Hamilton for replacements or corrections.

Supply Chain Leaders: Face immediate procurement challenges, as recalls force sudden demand for alternate products.

Patients: Indirectly affected through the potential for procedure delays, changes in equipment, or, in rare cases, adverse respiratory outcomes.

Dr. Laura Kim, Director of Perioperative Services at a major U.S. health system, emphasized:

“The Hamilton C6 is a sophisticated ventilator, often trusted for complex cases. A circuit board defect is not something clinicians can predict or prevent—this is why FDA alerts are so crucial.”

Meanwhile, Mark Hendrickson, a supply chain strategist, noted:

“When both consumable circuits and durable ventilators from the same vendor are under Class I alerts, hospitals must rethink vendor diversification. Relying too heavily on one supplier exposes systemic risk.”

FDA and Hamilton Recommendations

The FDA advises hospitals and surgical centers to:

1. Identify and quarantine affected breathing circuit sets from inventory.

2. Implement manufacturer-provided corrections for Hamilton-C6 ventilators, including circuit board replacements or updated instructions.

3. Train clinical staff on early detection of ventilation failure and emphasize readiness for backup manual ventilation.

4. Engage biomedical engineering teams to test and verify device integrity.

5. Report adverse events or near-misses through FDA’s MedWatch portal.

Hamilton Medical has committed to providing replacements for affected circuit sets and technical corrections for ventilators.

This dual recall illustrates a broader challenge in healthcare technology management:

Risk Consolidation: Hospitals that source both consumables and ventilators from a single manufacturer are more vulnerable to simultaneous product failures.

Readiness Pressure: Perioperative and ICU leaders must ensure immediate access to backup devices and alternative circuits to avoid case cancellations or emergency events.

Procurement Strategy: Many systems may consider vendor diversification, balancing reliance on established suppliers like Hamilton with contingency contracts.

Healthcare leaders should act immediately by:

• Auditing all Hamilton breathing circuits and C6 ventilators in stock.

• Quarantining affected lots and engaging Hamilton Medical for remediation.

• Reinforcing backup ventilation protocols across anesthesia and ICU team

• Preparing procurement strategies to secure alternate ventilators and circuits if needed.

• Documenting all adverse events and responses for internal and FDA reporting.